Insights+: Key Deals of JP Morgan Healthcare Conference 2021
Shots: The PHYOX 3 OLE study involves assessing of nedosiran in participants aged ≥6yrs. with PH1 or PH2 who have participated in any previous PHYOX clinical development program trial as well as their siblings aged 6-18yrs. with PH All participants regardless of PH subtype, achieved normal or near-normal Uox excretion @day180, 92% participants (100% & […]Read More